Thomas Shrader
Stock Analyst at BTIG
(2.23)
# 2,811
Out of 4,987 analysts
53
Total ratings
43.48%
Success rate
-0.58%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRUG Bright Minds Biosciences | Initiates: Buy | $72 | $45.38 | +58.68% | 1 | Sep 8, 2025 | |
| GANX Gain Therapeutics | Reiterates: Buy | $9 | $1.71 | +426.32% | 3 | Sep 8, 2025 | |
| ACIU AC Immune | Reiterates: Buy | $8 | $2.48 | +222.58% | 2 | Sep 8, 2025 | |
| BHVN Biohaven | Maintains: Buy | $59 → $60 | $14.93 | +301.88% | 3 | Aug 19, 2025 | |
| HROW Harrow | Maintains: Buy | $62 → $63 | $44.45 | +41.73% | 1 | Aug 14, 2025 | |
| VRNA Verona Pharma | Downgrades: Neutral | n/a | $106.32 | - | 4 | Jul 10, 2025 | |
| INMB INmune Bio | Downgrades: Neutral | n/a | $1.97 | - | 3 | Jul 1, 2025 | |
| ALDX Aldeyra Therapeutics | Maintains: Buy | $11 → $9 | $5.01 | +79.82% | 1 | Apr 7, 2025 | |
| OVID Ovid Therapeutics | Maintains: Buy | $5 → $4 | $1.15 | +247.83% | 3 | Mar 24, 2025 | |
| PCVX Vaxcyte | Reiterates: Buy | $160 | $31.70 | +404.73% | 4 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $18.82 | +117.85% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $5 | $3.01 | +66.11% | 2 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.76 | - | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.45 | +1,681.74% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $60 | $4.68 | +1,182.05% | 1 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $7 | $2.64 | +165.15% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.60 | +168.10% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $13 | $0.70 | +1,744.49% | 3 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $1.28 | +1,618.75% | 2 | Oct 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $1.48 | +3,357.63% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $3.26 | +390.80% | 1 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.37 | - | 1 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.27 | - | 2 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $58 | $15.01 | +286.41% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.31 | +129.01% | 3 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $397 → $346 | $144.27 | +139.83% | 3 | Feb 21, 2019 |
Bright Minds Biosciences
Sep 8, 2025
Initiates: Buy
Price Target: $72
Current: $45.38
Upside: +58.68%
Gain Therapeutics
Sep 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.71
Upside: +426.32%
AC Immune
Sep 8, 2025
Reiterates: Buy
Price Target: $8
Current: $2.48
Upside: +222.58%
Biohaven
Aug 19, 2025
Maintains: Buy
Price Target: $59 → $60
Current: $14.93
Upside: +301.88%
Harrow
Aug 14, 2025
Maintains: Buy
Price Target: $62 → $63
Current: $44.45
Upside: +41.73%
Verona Pharma
Jul 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $106.32
Upside: -
INmune Bio
Jul 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.97
Upside: -
Aldeyra Therapeutics
Apr 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $5.01
Upside: +79.82%
Ovid Therapeutics
Mar 24, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.15
Upside: +247.83%
Vaxcyte
Feb 24, 2025
Reiterates: Buy
Price Target: $160
Current: $31.70
Upside: +404.73%
Jan 28, 2025
Initiates: Buy
Price Target: $41
Current: $18.82
Upside: +117.85%
Nov 26, 2024
Maintains: Buy
Price Target: $16 → $5
Current: $3.01
Upside: +66.11%
Sep 4, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.76
Upside: -
Oct 3, 2023
Initiates: Buy
Price Target: $8
Current: $0.45
Upside: +1,681.74%
Jul 28, 2023
Maintains: Buy
Price Target: $180 → $60
Current: $4.68
Upside: +1,182.05%
May 25, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $2.64
Upside: +165.15%
May 18, 2023
Initiates: Buy
Price Target: $15
Current: $5.60
Upside: +168.10%
Mar 28, 2023
Maintains: Buy
Price Target: $68 → $13
Current: $0.70
Upside: +1,744.49%
Oct 5, 2022
Maintains: Buy
Price Target: $15 → $22
Current: $1.28
Upside: +1,618.75%
Apr 20, 2021
Initiates: Buy
Price Target: $51
Current: $1.48
Upside: +3,357.63%
Mar 8, 2021
Initiates: Buy
Price Target: $16
Current: $3.26
Upside: +390.80%
Feb 3, 2021
Downgrades: Neutral
Price Target: n/a
Current: $4.37
Upside: -
Oct 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $13.27
Upside: -
Sep 15, 2020
Maintains: Buy
Price Target: $51 → $58
Current: $15.01
Upside: +286.41%
Apr 3, 2020
Maintains: Buy
Price Target: $4 → $3
Current: $1.31
Upside: +129.01%
Feb 21, 2019
Downgrades: Hold
Price Target: $397 → $346
Current: $144.27
Upside: +139.83%